"Fibrinolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The natural enzymatic dissolution of FIBRIN.
Descriptor ID |
D005342
|
MeSH Number(s) |
G09.188.390.150.390
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolysis".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolysis".
This graph shows the total number of publications written about "Fibrinolysis" by people in this website by year, and whether "Fibrinolysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2004 | 1 | 1 | 2 |
2005 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2009 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2015 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrinolysis" by people in Profiles.
-
Viscoelastic coagulation monitoring for tranexamic acid: personalised antifibrinolytic dosing? Br J Anaesth. 2024 Feb; 132(2):227-229.
-
Disseminated intravascular coagulation and its immune mechanisms. Blood. 2022 03 31; 139(13):1973-1986.
-
Clot Retraction: Lost in Interpretation? Anesth Analg. 2019 04; 128(4):e53-e54.
-
Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: A systematic review and meta-analysis. Thromb Res. 2017 Dec; 160:1-8.
-
Sedentary behavior is associated with impaired biomarkers in claudicants. J Vasc Surg. 2016 Mar; 63(3):657-63.
-
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2014 Jun; 15(5):e198-205.
-
Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor a2-antiplasmin. J Thromb Haemost. 2011 May; 9(5):987-96.
-
Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites. J Biol Chem. 2011 Jun 03; 286(22):19280-6.
-
Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009 May; 108(5):1433-46.
-
Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent - a staphylokinase variant. Acta Biochim Pol. 2009; 56(1):41-53.